This site is intended for Healthcare professionals only.

Drug reverses brain deficits caused by binge-like alcohol consumption


Drug reverses  brain deficits caused by binge-like alcohol consumption

According to researchers of Queensland University of Technology (QUT) a new  drug tandospirone reverses the effects of 15 weeks of binge-like alcohol consumption on neurogenesis (the ability of the brain to grow and replace neurons) and potentially help our brains reboot .Their findings have been published in Scientific Reports.

Their studies in adult mice show that two weeks of daily treatment with the drug tandospirone  reverses the damaging impacts of heavy alcohol consumption on regeneration of brain cells .

  • This is the first time tandospirone has be shown to reverse the deficit in brain neurogenesis induced by heavy alcohol consumption
  • Tandospirone acts selectively on a serotonin receptor (5-HT1A)
  • The researchers also showed in mice that the drug was effective in stopping anxiety-like behaviours associated with alcohol withdrawal, and this was accompanied by a significant decrease in binge-like alcohol intake

“This is a novel discovery that tandospirone can reverse the deficit in neurogenesis caused by alcohol,” said study leader neuroscientist Professor Selena Bartlett from QUT’s Institute of Health and Biomedical Innovation.

“We know that with heavy drinking you are inhibiting your ability to grow new neurons, brain cells. Alcohol is specifically very damaging for neurons.

“Other studies in mice have shown that tandospirone improves brain neurogenesis, but this is the first time it has been shown that it can totally reverse the neurogenic deficits induced by alcohol.

“This opens the way to look at if neurogenesis is associated with other substance-abuse deficits, such as in memory and learning, and whether this compound can reverse these.”

Professor Bartlett, who is based at the Translational Research Institute, said the discovery by study co-authors QUT postdoctoral research fellows Dr Arnauld Belmer and Dr Omkar Patkar came about serendipitously after research started in a different direction.

“It was surprising, and exciting,” Dr Belmer said.

“This drug is relatively new and available only in China and Japan. It is commonly used there and shown to be highly effective in treating general anxiety and well tolerated with limited adverse effects.”

Professor Bartlett said researchers are constantly looking at new treatment strategies for alcohol abuse and addiction, which is characterised by extended periods of heavy alcohol use, binges and abstinence, and anxiety and depression which contribute to relapse.

“This is not just another drug that shows promise in helping to reduce binge drinking,” she said.

“While it could possibly have that effect, it might be able to help reboot the brain and reverse the deficits the alcohol abuse causes — both the inhibition to the brain’s ability to regenerate, and the behavioural consequences that come from what alcohol is doing to the brain, like increases in anxiety and depression.”

For more details click on the link : Scientific Reports, 2018; 8 (1) DOI: 10.1038/s41598-018-20504-z

The following two tabs change content below.
Anjali Nimesh

Anjali Nimesh

Anjali Nimesh Joined Medical Dialogue as Reporter in 2016. she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Dr. Bhimrao Ambedkar University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Source: Press Release

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted